
|Videos|May 29, 2013
The 340B Drug Discount Program
Adam J. Fein describes how the 340B program is being exploited by many hospital systems due to a lack of oversight by government agencies.
Advertisement
In this video, Adam J. Fein describes how the 340B program is being exploited by many hospital systems due to a lack of oversight by government agencies.
For more information about Dr. Fein's controversial op-ed on 340B pricing, see
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, ASH Experts Review Newly Approved Therapies in Hemophilia
2
How a New Generation of CAR T-Cell Therapies Could Reduce the Risk of Rejection
3
Pharmacist Strategies for Managing Comorbid Depression and Diabetes
4
A Cup of Coffee or Life-Saving Drugs: Shifting Decision-Making Practices in Health Care
5




















































































































































































































